<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
16262-014-01
</NDCCode>
<PackageDescription>
85714 TABLET in 1 BAG (16262-014-01)
</PackageDescription>
<NDC11Code>
16262-0014-01
</NDC11Code>
<ProductNDC>
16262-014
</ProductNDC>
<ProductTypeName>
DRUG FOR FURTHER PROCESSING
</ProductTypeName>
<ProprietaryName/>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Sodium Alendronate
</NonProprietaryName>
<DosageFormName>
TABLET
</DosageFormName>
<RouteName/>
<StartMarketingDate>
20151019
</StartMarketingDate>
<EndMarketingDate>
20271130
</EndMarketingDate>
<MarketingCategoryName>
DRUG FOR FURTHER PROCESSING
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
Aesica Pharmaceuticals GmbH, Zwickau
</LabelerName>
<SubstanceName>
ALENDRONIC ACID
</SubstanceName>
<StrengthNumber>
70
</StrengthNumber>
<StrengthUnit>
mg/1
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Unfinished
</Status>
<LastUpdate>
2024-11-27
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag/>
<ListingRecordCertifiedThrough/>
<StartMarketingDatePackage>
19-OCT-15
</StartMarketingDatePackage>
<EndMarketingDatePackage>
30-NOV-27
</EndMarketingDatePackage>
<SamplePackage/>
</NDC>